Physician profile
Richard Silver
NPI 1881647212
$3,034.50
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $1,056 · 2021: $743 · 2022: $165 · 2023: $52.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $52.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $52.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $529.63 | 2019-2022 | |
| Abbvie INC. | $327.16 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $246.88 | 2019-2020 | |
| Grifols USA, LLC | $224.52 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $171.03 | 2019-2022 | |
| Glaxosmithkline, LLC. | $167.12 | 2019-2021 | |
| Covis Pharma Gmbh | $135.54 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.52 | 2019-2022 | |
| Sobi, INC | $117.68 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.07 | 2020-2021 | |
| Philips North America LLC | $90.88 | 2019-2020 | |
| Csl Behring | $78.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $77.99 | 2020-2021 | |
| Chiesi USA, INC. | $73.94 | 2020-2021 | |
| Shire North American Group INC | $72.58 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $61.47 | 2019-2020 | |
| Genzyme Corporation | $57.36 | 2019-2020 | |
| Aytu Biopharma, INC. | $55.38 | 2020-2021 | |
| Pharming Healthcare, INC. | $52.00 | 2023 | |
| Nestle Healthcare Nutrition INC. | $49.17 | 2020-2021 | |
| Genentech USA, INC. | $45.06 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $41.83 | 2021 | |
| Mylan Specialty L.P. | $39.02 | 2019-2020 | |
| Gilead Sciences, INC. | $21.03 | 2020 | |
| Allergan, INC. | $19.74 | 2019 | |
| Amgen INC. | $19.55 | 2021 | |
| Vivus LLC | $15.19 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.